<DOC>
	<DOCNO>NCT01521884</DOCNO>
	<brief_summary>People affect rheumatoid arthritis often suffer fatigue decrease QOL . In study measure impact SC biologics parameter .</brief_summary>
	<brief_title>Study Looking Longitudinal Changes Fatigue Health Status Rheumatoid Arthritis ( RA ) Patients Treated With Subcutaneous Anti-TNF-α Therapy</brief_title>
	<detailed_description>Observational prospective study Purely descriptive</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Patients : Are active RA patient ( judged treat MD ) Are 18 year age old time consent Are schedule rheumatologist initiate SC antiTNFα therapy + MTX Use biologics ( experimental drug ) last 3 month initiation SC antiTNFα therapy . Participation clinical observational trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>